Manaksia Aluminium Company Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 12, 2025, 3:40 pm

Competitors of Manaksia Aluminium Company Ltd

All Competitor Stocks of Manaksia Aluminium Company Ltd

Quarterly Result

Last Updated: August 20, 2025, 7:20 am

Below is a detailed analysis of the quarterly data for Manaksia Aluminium Company Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 134.41 Cr.. The value appears to be declining and may need further review. It has decreased from 137.07 Cr. (Mar 2025) to 134.41 Cr., marking a decrease of 2.66 Cr..
• For Expenses, as of Jun 2025, the value is 123.16 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 125.64 Cr. (Mar 2025) to 123.16 Cr., marking a decrease of 2.48 Cr..
• For Operating Profit, as of Jun 2025, the value is 11.25 Cr.. The value appears to be declining and may need further review. It has decreased from 11.43 Cr. (Mar 2025) to 11.25 Cr., marking a decrease of 0.18 Cr..
• For OPM %, as of Jun 2025, the value is 8.37%. The value appears strong and on an upward trend. It has increased from 8.34% (Mar 2025) to 8.37%, marking an increase of 0.03%.
• For Other Income, as of Jun 2025, the value is 0.16 Cr.. The value appears to be declining and may need further review. It has decreased from 0.40 Cr. (Mar 2025) to 0.16 Cr., marking a decrease of 0.24 Cr..
• For Interest, as of Jun 2025, the value is 7.06 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6.75 Cr. (Mar 2025) to 7.06 Cr., marking an increase of 0.31 Cr..
• For Depreciation, as of Jun 2025, the value is 2.31 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.21 Cr. (Mar 2025) to 2.31 Cr., marking an increase of 0.10 Cr..
• For Profit before tax, as of Jun 2025, the value is 2.04 Cr.. The value appears to be declining and may need further review. It has decreased from 2.87 Cr. (Mar 2025) to 2.04 Cr., marking a decrease of 0.83 Cr..
• For Tax %, as of Jun 2025, the value is 24.02%. The value appears to be improving (decreasing) as expected. It has decreased from 30.31% (Mar 2025) to 24.02%, marking a decrease of 6.29%.
• For Net Profit, as of Jun 2025, the value is 1.56 Cr.. The value appears to be declining and may need further review. It has decreased from 2.00 Cr. (Mar 2025) to 1.56 Cr., marking a decrease of 0.44 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.24. The value appears to be declining and may need further review. It has decreased from 0.31 (Mar 2025) to 0.24, marking a decrease of 0.07.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 4:53 am

Balance Sheet

Last Updated: September 10, 2025, 2:02 pm

Below is a detailed analysis of the balance sheet data for Manaksia Aluminium Company Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 7.00 Cr..
• For Reserves, as of Mar 2025, the value is 129.00 Cr.. The value appears strong and on an upward trend. It has increased from 123.00 Cr. (Mar 2024) to 129.00 Cr., marking an increase of 6.00 Cr..
• For Borrowings, as of Mar 2025, the value is 239.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 172.00 Cr. (Mar 2024) to 239.00 Cr., marking an increase of 67.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 130.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 116.00 Cr. (Mar 2024) to 130.00 Cr., marking an increase of 14.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 504.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 418.00 Cr. (Mar 2024) to 504.00 Cr., marking an increase of 86.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 119.00 Cr.. The value appears strong and on an upward trend. It has increased from 111.00 Cr. (Mar 2024) to 119.00 Cr., marking an increase of 8.00 Cr..
• For CWIP, as of Mar 2025, the value is 28.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2024) to 28.00 Cr., marking an increase of 18.00 Cr..
• For Investments, as of Mar 2025, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 1.00 Cr., marking an increase of 1.00 Cr..
• For Other Assets, as of Mar 2025, the value is 357.00 Cr.. The value appears strong and on an upward trend. It has increased from 296.00 Cr. (Mar 2024) to 357.00 Cr., marking an increase of 61.00 Cr..
• For Total Assets, as of Mar 2025, the value is 504.00 Cr.. The value appears strong and on an upward trend. It has increased from 418.00 Cr. (Mar 2024) to 504.00 Cr., marking an increase of 86.00 Cr..

However, the Borrowings (239.00 Cr.) are higher than the Reserves (129.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Manaksia Aluminium Company Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 0.92. This value is below the healthy minimum of 5. It has increased from 0.78 (Mar 24) to 0.92, marking an increase of 0.14.
• For Diluted EPS (Rs.), as of Mar 25, the value is 0.92. This value is below the healthy minimum of 5. It has increased from 0.78 (Mar 24) to 0.92, marking an increase of 0.14.
• For Cash EPS (Rs.), as of Mar 25, the value is 2.19. This value is below the healthy minimum of 3. It has increased from 1.97 (Mar 24) to 2.19, marking an increase of 0.22.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 20.65. It has increased from 19.81 (Mar 24) to 20.65, marking an increase of 0.84.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 20.65. It has increased from 19.81 (Mar 24) to 20.65, marking an increase of 0.84.
• For Dividend / Share (Rs.), as of Mar 25, the value is 0.07. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.07.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 77.69. It has increased from 66.00 (Mar 24) to 77.69, marking an increase of 11.69.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 6.70. This value is within the healthy range. It has increased from 5.49 (Mar 24) to 6.70, marking an increase of 1.21.
• For PBIT / Share (Rs.), as of Mar 25, the value is 5.43. This value is within the healthy range. It has increased from 4.30 (Mar 24) to 5.43, marking an increase of 1.13.
• For PBT / Share (Rs.), as of Mar 25, the value is 1.23. This value is within the healthy range. It has increased from 1.00 (Mar 24) to 1.23, marking an increase of 0.23.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 0.92. This value is below the healthy minimum of 2. It has increased from 0.77 (Mar 24) to 0.92, marking an increase of 0.15.
• For PBDIT Margin (%), as of Mar 25, the value is 8.62. This value is below the healthy minimum of 10. It has increased from 8.32 (Mar 24) to 8.62, marking an increase of 0.30.
• For PBIT Margin (%), as of Mar 25, the value is 6.99. This value is below the healthy minimum of 10. It has increased from 6.50 (Mar 24) to 6.99, marking an increase of 0.49.
• For PBT Margin (%), as of Mar 25, the value is 1.58. This value is below the healthy minimum of 10. It has increased from 1.52 (Mar 24) to 1.58, marking an increase of 0.06.
• For Net Profit Margin (%), as of Mar 25, the value is 1.18. This value is below the healthy minimum of 5. It has increased from 1.17 (Mar 24) to 1.18, marking an increase of 0.01.
• For Return on Networth / Equity (%), as of Mar 25, the value is 4.46. This value is below the healthy minimum of 15. It has increased from 3.91 (Mar 24) to 4.46, marking an increase of 0.55.
• For Return on Capital Employeed (%), as of Mar 25, the value is 18.04. This value is within the healthy range. It has increased from 16.06 (Mar 24) to 18.04, marking an increase of 1.98.
• For Return On Assets (%), as of Mar 25, the value is 1.19. This value is below the healthy minimum of 5. It has decreased from 1.21 (Mar 24) to 1.19, marking a decrease of 0.02.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.35. This value is within the healthy range. It has increased from 0.25 (Mar 24) to 0.35, marking an increase of 0.10.
• For Total Debt / Equity (X), as of Mar 25, the value is 1.77. This value exceeds the healthy maximum of 1. It has increased from 1.33 (Mar 24) to 1.77, marking an increase of 0.44.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.10. It has increased from 1.09 (Mar 24) to 1.10, marking an increase of 0.01.
• For Current Ratio (X), as of Mar 25, the value is 1.16. This value is below the healthy minimum of 1.5. It has decreased from 1.21 (Mar 24) to 1.16, marking a decrease of 0.05.
• For Quick Ratio (X), as of Mar 25, the value is 0.49. This value is below the healthy minimum of 1. It has decreased from 0.55 (Mar 24) to 0.49, marking a decrease of 0.06.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.80. This value is below the healthy minimum of 4. It has decreased from 2.90 (Mar 24) to 2.80, marking a decrease of 0.10.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 7.58. This value is below the healthy minimum of 20. It has increased from 6.44 (Mar 24) to 7.58, marking an increase of 1.14.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 3.19. This value is below the healthy minimum of 20. It has increased from 2.53 (Mar 24) to 3.19, marking an increase of 0.66.
• For Earning Retention Ratio (%), as of Mar 25, the value is 92.42. This value exceeds the healthy maximum of 70. It has decreased from 93.56 (Mar 24) to 92.42, marking a decrease of 1.14.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 96.81. This value exceeds the healthy maximum of 70. It has decreased from 97.47 (Mar 24) to 96.81, marking a decrease of 0.66.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 1.60. This value is below the healthy minimum of 3. It has decreased from 1.67 (Mar 24) to 1.60, marking a decrease of 0.07.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.22. This value is below the healthy minimum of 3. It has decreased from 1.24 (Mar 24) to 1.22, marking a decrease of 0.02.
• For Enterprise Value (Cr.), as of Mar 25, the value is 338.72. It has increased from 328.66 (Mar 24) to 338.72, marking an increase of 10.06.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.66. This value is below the healthy minimum of 1. It has decreased from 0.75 (Mar 24) to 0.66, marking a decrease of 0.09.
• For EV / EBITDA (X), as of Mar 25, the value is 7.71. This value is within the healthy range. It has decreased from 9.13 (Mar 24) to 7.71, marking a decrease of 1.42.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 1. It has decreased from 0.38 (Mar 24) to 0.23, marking a decrease of 0.15.
• For Retention Ratios (%), as of Mar 25, the value is 92.41. This value exceeds the healthy maximum of 70. It has decreased from 93.55 (Mar 24) to 92.41, marking a decrease of 1.14.
• For Price / BV (X), as of Mar 25, the value is 0.89. This value is below the healthy minimum of 1. It has decreased from 1.30 (Mar 24) to 0.89, marking a decrease of 0.41.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 1. It has decreased from 0.38 (Mar 24) to 0.23, marking a decrease of 0.15.
• For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.05, marking an increase of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness